• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃塞俄比亚霍罗古杜鲁瓦拉加地区公共卫生设施中接受抗逆转录病毒治疗的艾滋病毒患者的死亡时间及其预测因素:一项回顾性队列研究

Time to death and its predictors among HIV patients on antiretroviral therapy in public health facilities of Horro Guduru Wallaga zone, Ethiopia: a retrospective cohort study.

作者信息

Morka Benti, Belay Keno Firezer, Gebre Dejene Seyoum, Fikadu Worku, Tiruneh Gemechu, Golja Eba Abdisa, Ewunetu Adisu

机构信息

Horro Guduru Wallaga Zone Health Department, Shambu, Ethiopia.

School of Public Health, Institute of Health Science, Wallaga University, Nekemte, Ethiopia.

出版信息

Front Public Health. 2025 Apr 16;13:1565573. doi: 10.3389/fpubh.2025.1565573. eCollection 2025.

DOI:10.3389/fpubh.2025.1565573
PMID:40308933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12040889/
Abstract

BACKGROUND

People with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) continue to die at substantial rates, even in our nation of Ethiopia, despite receiving antiretroviral medication. Limited evidence is available regarding these individuals' time to death and its predictors. Therefore, this study aimed to evaluate time to death and its predictors among HIV/AIDS patients receiving antiretroviral therapy (ART) in this study area.

OBJECTIVE

The objective of the study was to assess time to death and its predictors among HIV patients receiving ART in public facilities of the Horro Guduru Wallaga (HGW) zone, Western Ethiopia, 2024.

METHODS AND MATERIALS

A facility-based retrospective study was conducted involving 538 HIV-positive patients on anti-retroviral therapy. A simple random sampling method was used to select a sample from patient registrations between October 2018 and October 2023. Data were entered into EpiData version 3.1 and exported to STATA version 14. The Kaplan-Meier curve was used to estimate the survival probability after ART initiation. The Cox regression model was used to identify independent predictors of death. Significantly associated variables were reported with a -value of less than 0.05 and the adjusted hazard ratio (AHR) with a 95% confidence interval.

RESULTS

Among the 538 study participants included in the final analysis, 42 (8%) individuals died. The finding of this study revealed that the incidence rate of HIV-related death was 2.81 deaths per 1,000 person-months. Diarrhea (AHR = 4.54; 95% CI 1.85-11.13), failure to take TB prophylaxis (AHR = 5.61; 95%CI: 2.25, 14.03), non-utilization of condoms (AHR = 2.62; 95% CI: 1.13, 6.08), and WHO clinical stages III and IV (AHR = 7.02; 95%CI: 3.11, 11.84) were identified as predictors of death among the patients.

CONCLUSION

The time to death among HIV patients on ART in this study area was higher compared to the national HIV-related death report. A history of diarrhea, failure to adhere to tuberculosis prophylaxis, non-utilization of condoms, and HIV clinical stages III and IV were found to be predictors of time to death related to HIV. Therefore, it is important to promote behavioral changes, such as condom utilization, adherence to TB prophylaxis, and effective treatment of comorbid infections, to improve the lifespan of HIV patients.

摘要

背景

即使在我们埃塞俄比亚这个国家,感染人类免疫缺陷病毒(HIV)/获得性免疫缺陷综合征(AIDS)的人在接受抗逆转录病毒药物治疗的情况下,仍有相当高的死亡率。关于这些人的死亡时间及其预测因素的证据有限。因此,本研究旨在评估该研究地区接受抗逆转录病毒治疗(ART)的HIV/AIDS患者的死亡时间及其预测因素。

目的

本研究的目的是评估2024年埃塞俄比亚西部霍罗古杜鲁瓦拉加(HGW)地区公共设施中接受ART的HIV患者的死亡时间及其预测因素。

方法和材料

进行了一项基于机构的回顾性研究,涉及538名接受抗逆转录病毒治疗的HIV阳性患者。采用简单随机抽样方法从2018年10月至2023年10月期间的患者登记记录中选取样本。数据录入EpiData 3.1版本,并导出到STATA 14版本。使用Kaplan-Meier曲线估计开始ART后的生存概率。使用Cox回归模型确定死亡的独立预测因素。报告具有显著相关性的变量时,P值小于0.05,并给出调整后的风险比(AHR)及其95%置信区间。

结果

在最终分析纳入的538名研究参与者中,42人(8%)死亡。本研究结果显示,HIV相关死亡的发生率为每1000人月2.81例死亡。腹泻(AHR = 4.54;95% CI 1.85 - 11.13)、未采取结核病预防措施(AHR = 5.61;95%CI:2.25,14.03)、未使用避孕套(AHR = 2.62;95% CI:1.13,6.08)以及世界卫生组织临床分期III和IV期(AHR = 7.02;95%CI:3.11,11.84)被确定为患者死亡的预测因素。

结论

与全国HIV相关死亡报告相比,该研究地区接受ART的HIV患者的死亡时间更高。腹泻病史、未坚持结核病预防、未使用避孕套以及HIV临床分期III和IV期被发现是与HIV相关的死亡时间的预测因素。因此,促进行为改变,如使用避孕套、坚持结核病预防以及有效治疗合并感染,对于提高HIV患者的寿命很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/5b4e0e109e4e/fpubh-13-1565573-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/56bea9b73dd2/fpubh-13-1565573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/48eee93c65da/fpubh-13-1565573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/f826114bb4dd/fpubh-13-1565573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/4c214aada82a/fpubh-13-1565573-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/a2e05ca66146/fpubh-13-1565573-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/2805199c386f/fpubh-13-1565573-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/d03bb3651984/fpubh-13-1565573-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/5b4e0e109e4e/fpubh-13-1565573-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/56bea9b73dd2/fpubh-13-1565573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/48eee93c65da/fpubh-13-1565573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/f826114bb4dd/fpubh-13-1565573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/4c214aada82a/fpubh-13-1565573-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/a2e05ca66146/fpubh-13-1565573-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/2805199c386f/fpubh-13-1565573-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/d03bb3651984/fpubh-13-1565573-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/12040889/5b4e0e109e4e/fpubh-13-1565573-g008.jpg

相似文献

1
Time to death and its predictors among HIV patients on antiretroviral therapy in public health facilities of Horro Guduru Wallaga zone, Ethiopia: a retrospective cohort study.埃塞俄比亚霍罗古杜鲁瓦拉加地区公共卫生设施中接受抗逆转录病毒治疗的艾滋病毒患者的死亡时间及其预测因素:一项回顾性队列研究
Front Public Health. 2025 Apr 16;13:1565573. doi: 10.3389/fpubh.2025.1565573. eCollection 2025.
2
Incidence and predictors of mortality among HIV positive children on anti-retroviral therapy in the selected health facilities of West Wollega Zone, Western Ethiopia: Retrospective cohort study.埃塞俄比亚西部沃莱加区选定卫生设施中接受抗逆转录病毒治疗的艾滋病毒阳性儿童的死亡率及预测因素:回顾性队列研究
PLoS One. 2025 Jan 24;20(1):e0314112. doi: 10.1371/journal.pone.0314112. eCollection 2025.
3
Survival and predictors of mortality among HIV-infected adults after initiation of antiretroviral therapy in Eastern Ethiopia Governmental hospitals, from January 2015 to December 2021 (multi-center retrospective follow-up study).2015 年 1 月至 2021 年 12 月期间,在埃塞俄比亚东部政府医院接受抗逆转录病毒治疗的 HIV 感染成年人的生存和死亡率预测因素(多中心回顾性随访研究)。
BMC Infect Dis. 2024 Nov 27;24(1):1352. doi: 10.1186/s12879-024-10225-2.
4
Incidence and predictors of loss to follow-up among adult HIV patients attending antiretroviral therapy at public health facilities in Agaro town, Southwest Ethiopia, 2023.2023年埃塞俄比亚西南部阿加罗镇公共卫生机构接受抗逆转录病毒治疗的成年艾滋病毒患者失访的发生率及预测因素
BMC Infect Dis. 2025 Mar 1;25(1):297. doi: 10.1186/s12879-025-10646-7.
5
Incidence and predictors of opportunistic infections among HIV-infected children on antiretroviral therapy at public health facilities of Southwest Ethiopia People Regional State, 2023: a multicenter retrospective follow-up study.2023 年,在埃塞俄比亚西南部地区公共卫生机构接受抗逆转录病毒疗法的 HIV 感染儿童中,机会性感染的发生率和预测因素:一项多中心回顾性随访研究。
BMC Pediatr. 2024 Oct 11;24(1):653. doi: 10.1186/s12887-024-05117-y.
6
Incidence of death and its predictors among TB/HIV coinfected adult patients receiving anti-retroviral therapy at Gambelia referral hospital, Southwest Ethiopia, 2022.2022年埃塞俄比亚西南部甘贝利阿转诊医院接受抗逆转录病毒治疗的结核病/艾滋病合并感染成年患者的死亡发生率及其预测因素
BMC Infect Dis. 2025 Apr 10;25(1):500. doi: 10.1186/s12879-025-10878-7.
7
Competing risks multi-state model for time-to-event data analysis of HIV/AIDS: a retrospective cohort national datasets, Ethiopia.用于艾滋病毒/艾滋病事件发生时间数据分析的竞争风险多状态模型:埃塞俄比亚全国回顾性队列数据集
BMC Infect Dis. 2024 Dec 18;24(1):1412. doi: 10.1186/s12879-024-10280-9.
8
Incidence and predictors of anemia among adults on HIV care at South Gondar Zone Public General Hospital Northwest Ethiopia, 2020; retrospective cohort study.2020 年,在埃塞俄比亚西北部南贡达尔地区公立综合医院接受艾滋病毒护理的成年人贫血发生率及其预测因素:回顾性队列研究。
PLoS One. 2022 Jan 12;17(1):e0259944. doi: 10.1371/journal.pone.0259944. eCollection 2022.
9
Incidence of loss to follow-up and its predictors among HIV-infected under-five children after initiation of antiretroviral therapy in West Amhara Comprehensive Specialized Referral Hospitals, Northwest Ethiopia: a multicenter retrospective follow-up study.在埃塞俄比亚西北部的西阿姆哈拉综合专科医院,接受抗逆转录病毒治疗的五岁以下 HIV 感染儿童中,随访失败的发生率及其预测因素:一项多中心回顾性随访研究。
BMC Pediatr. 2024 Sep 28;24(1):615. doi: 10.1186/s12887-024-05086-2.
10
Incidence and predictors of treatment failure among children on first-line antiretroviral therapy in Amhara Region Referral Hospitals, northwest Ethiopia 2018: A retrospective study.2018 年埃塞俄比亚阿姆哈拉地区转诊医院一线抗逆转录病毒治疗失败儿童的发生率及预测因素:一项回顾性研究。
PLoS One. 2019 May 1;14(5):e0215300. doi: 10.1371/journal.pone.0215300. eCollection 2019.

本文引用的文献

1
Survival and predictors of mortality among HIV-infected adults after initiation of antiretroviral therapy in Eastern Ethiopia Governmental hospitals, from January 2015 to December 2021 (multi-center retrospective follow-up study).2015 年 1 月至 2021 年 12 月期间,在埃塞俄比亚东部政府医院接受抗逆转录病毒治疗的 HIV 感染成年人的生存和死亡率预测因素(多中心回顾性随访研究)。
BMC Infect Dis. 2024 Nov 27;24(1):1352. doi: 10.1186/s12879-024-10225-2.
2
Mortality and its predictors among human immunodeficiency virus-infected children younger than 15 years receiving antiretroviral therapy in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚接受抗逆转录病毒治疗的15岁以下感染人类免疫缺陷病毒儿童的死亡率及其预测因素:一项系统评价和荟萃分析
BMC Infect Dis. 2024 May 3;24(1):471. doi: 10.1186/s12879-024-09366-1.
3
Predictors of Mortality Among Children and Adolescents Living With HIV on Antiretroviral Therapy in Western Kenya.肯尼亚西部接受抗逆转录病毒治疗的 HIV 阳性儿童和青少年的死亡预测因素。
J Acquir Immune Defic Syndr. 2024 Apr 1;95(4):383-390. doi: 10.1097/QAI.0000000000003361.
4
Time to death and its predictors among under-five children on antiretroviral treatment in public hospitals of Addis Ababa, Addis Ababa, Ethiopia, a retrospective follow up study.在埃塞俄比亚亚的斯亚贝巴市的公立医院中,接受抗逆转录病毒治疗的五岁以下儿童的死亡时间及其预测因素:一项回顾性随访研究。
PLoS One. 2023 Jul 20;18(7):e0288475. doi: 10.1371/journal.pone.0288475. eCollection 2023.
5
Key populations and Sub-Saharan Africa's HIV response.重点人群与撒哈拉以南非洲地区的艾滋病应对措施。
Front Public Health. 2023 May 16;11:1079990. doi: 10.3389/fpubh.2023.1079990. eCollection 2023.
6
Survival time and predictors of death among HIV infected under five children after initiation of anti -retroviral therapy in West Amhara Referral Hospitals, Northwest Ethiopia.在埃塞俄比亚西北部的西阿姆哈拉转诊医院,开始抗逆转录病毒治疗后,五岁以下艾滋病毒感染儿童的生存时间和死亡预测因素。
BMC Pediatr. 2022 Nov 21;22(1):670. doi: 10.1186/s12887-022-03693-5.
7
Incidence and predictors of mortality among adolescents on antiretroviral therapy in Amhara Region, Ethiopia: a retrospective cohort analysis.在埃塞俄比亚阿姆哈拉地区,接受抗逆转录病毒疗法的青少年死亡率的发生率和预测因素:一项回顾性队列分析。
BMJ Open. 2022 Nov 9;12(11):e063879. doi: 10.1136/bmjopen-2022-063879.
8
Mortality and Its Predictors among Adult Human Immune-Deficiency Virus-Infected Patients Attending Their Antiretroviral Treatment at Health Centers, Addis Ababa, Ethiopia: Multicenter Retrospective Cohort Study.埃塞俄比亚亚的斯亚贝巴市在健康中心接受抗逆转录病毒治疗的成年人类免疫缺陷病毒感染患者的死亡率及其预测因素:多中心回顾性队列研究
AIDS Res Treat. 2022 Sep 19;2022:6128718. doi: 10.1155/2022/6128718. eCollection 2022.
9
Retention on antiretroviral therapy in person with HIV and viral hepatitis coinfection in Ethiopia: a retrospective cohort study.艾滋病毒和病毒性肝炎合并感染患者在埃塞俄比亚接受抗逆转录病毒治疗的保留率:一项回顾性队列研究。
BMC Public Health. 2022 Apr 4;22(1):644. doi: 10.1186/s12889-022-13025-y.
10
Predictors of Mortality among Adult People Living with HIV and Its Implications for Appointment Spacing Model Approach Care.成人艾滋病毒感染者死亡率的预测因素及其对预约间隔模式方法护理的影响。
Ethiop J Health Sci. 2021 Sep;31(5):925-936. doi: 10.4314/ejhs.v31i5.3.